期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

异基因造血干细胞移植治疗重型再生障碍性贫血71例临床分析 被引量：5

Clinical analysis of allogeneic hematopoietic stem cell transplantation for treatment of 71 cases of severe aplastic anemia
原文传递
导出
摘要 异基因造血干细胞移植（allo-HSCT）是目前治疗重型再生障碍性贫血（SAA）的重要手段。为了探讨allo—HSCT治疗SAA的临床疗效及预后影响因素，我们回顾性分析了71例接受allo—HSCT的SAA患者，现报告如下。
作者 宋媛 宋宁霞 刘希民 孔凡盛 方圆 解琳娜 余喆 宋晓晨 周芳
机构地区 济南军区总医院血液科
出处 《中华血液学杂志》 CAS CSCD 北大核心 2016年第2期151-153,共3页 Chinese Journal of Hematology
关键词 异基因造血干细胞移植 重型再生障碍性贫血 移植治疗 临床分析 HSCT 影响因素 临床疗效 SAA
分类号 R556.5 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献11

  • 1FouillardL, LabopinM, GratwohlA, et al. Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry[J]. Bone Marrow Transplant,2002,30(10):637-643.
  • 2PasswegJR, PérezWS, EapenM, et al. Bone marrow trans-plants from mismatched related and unrelated donors for severe aplastic anemia[J]. Bone Marrow Transplant,2006,37(7):641-649.
  • 3ScheinbergP, WuCO, NunezO, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine[J]. J Pediatr,2008,153(6):814-819. doi:10.1016/j.jpeds.2008.06.004.
  • 4PasswegJR, MarshJC. Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation[J]. Hematology Am Soc Hematol Educ Program,2010,2010:36-42. doi:10.1182/asheducation-2010.1.36.
  • 5KobayashiR, YabeH, HaraJ, et al. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings[J]. Br J Haematol,2006,135(5):693-696.
  • 6AdesL, MaryJY, RobinM, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia[J]. Blood,2004,103(7):2490-2497.
  • 7ChenJ, LeeV, LuoCJ, et al. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group[J]. Br J Haematol,2013,162(3):383-391. doi:10.1111/bjh.12405.
  • 8陈欣,魏嘉璘,黄勇,何炜,杨栋林,姜尔烈,马巧玲,周卢琨,林小婷,申昱妍,冯四洲,韩明哲.HLA匹配同胞供者异基因造血干细胞移植治疗重型再生障碍性贫血41例疗效分析[J].中华血液学杂志,2012,33(8):610-614. 被引量：11
  • 9陈欣,魏嘉璘,黄勇,何祎,杨栋林,姜尔烈,马巧玲,姚剑峰,周卢琨,林小婷,申昱妍,杨欣,王钊,冯四洲,韩明哲.替代供者异基因造血干细胞移植治疗重型再生障碍性贫血19例疗效分析[J].中华血液学杂志,2014,35(1):9-12. 被引量：12
  • 10StorbR, BlumeKG, O'DonnellMR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers[J]. Biol Blood Marrow Transplant,2001,7(1):39-44.

二级参考文献27

  • 1何祎,冯四洲,王玫,魏嘉璘,秦铁军,周征,翟文静,邱录贵,韩明哲.HLA相合同胞异基因造血干细胞移植治疗慢性粒细胞白血病第1次慢性期51例分析[J].中华血液学杂志,2005,26(7):389-392. 被引量：15
  • 2Passweg JR, Marsh JC. Aplastic anemia: first-line treatment by immuno suppression and sibling marrow transplantation. Hematology Am Soc Hematol Educ Program,2010,36-42.
  • 3Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade : a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 2007, 92 : 11-18.
  • 4Sangiolo D, Storb R, Deeg H J, et al. Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant, 2010, 16 : 1411-1418.
  • 5Maury S, Bacigalupo A, Anderlini P, et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. Haematologica, 2009, 94 : 1312- 1315.
  • 6Kim H, Lee KH, Yoon SS, et al. Allogeneic hematopoietic stem cell transplant for adults over 40 years old with acquired aplastic anemia. Biol Blood Marrow Transplant,2012,1. doi: 10. 1016/j. bbmt. 2012.03.015.
  • 7Chu R, Brazauskas R, Kan F, et al. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant, 2011, 17 : 1018-1024.
  • 8Bacigalupo A, Socie' G, Schrezenmeier H, et al. Bone marrow versus peripheral blood sibling transplants in acquired aplastic anemia: survival advantage for marrow in all age groups. Haematologica,2012,7. DOI : 10. 3324/haematol. 2011. 054841.
  • 9Jaime-Perez JC, Ruiz-Arguelles GJ, Gomez-Almaguer D. Haematopoietic stem cell transplantation to treat aplastic anaemia. Expert Opin Biol Ther, 2005, 5:617-626.
  • 10Passweg J R, Perez WS, Eapen M, et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant ,2006,37:641-649.

共引文献21

同被引文献42

  • 1MarshJC, BallSE, CavenaghJ, et al. Guidelines for the diagnosis and management of aplastic anaemia [J]. Br J Haematol, 2009, 147(1):43–70. doi: 10.1111/j.1365-2141.2009. 07842.x.
  • 2YagasakiH, TakahashiY, HamaA, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia[J]. Bone Marrow Transplant, 2010, 45 (10):1508–1513. doi: 10.1038/bmt.2009.378.
  • 3LeBK, SamuelssonH, GustafssonB, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells [J]. Leukemia, 2007, 21 (8):1733–1738. doi: 10.1038/sj.leu.2404777.
  • 4SillaL, ValimV, AmorinB, et al. A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil [J]. Leuk Lymphoma, 2014, 55 (5):1203–1205. doi: 10.3109/10428194.2013.823495.
  • 5HorwitzEM, MaziarzRT, KebriaeiP. MSCs in hematopoietic cell transplantation [J]. Biol Blood Marrow Transplant, 2011, 17 (1Suppl): S21–S29. doi: 10.1016/j.bbmt.2010.11.026.
  • 6WangH, WangZ, ZhengX, et al. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience [J]. Cytotherapy, 2013, 15 (9):1118–1125. doi: 10. 1016/j.jcyt.2013.04.007.
  • 7DufourC, PillonM, SocièG, et al. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant [J]. Br J Haematol, 2015, 169(4):565–573. doi: 10.1111/bjh.13297.
  • 8KimEJ, KimN, ChoSG. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation [J]. Exp Mol Med, 2013, 45:e2. doi: 10.1038/emm.2013.2.
  • 9DufourC, VeysP, CarraroE, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT [J]. Br J Haematol, 2015, 171 (4):585–594. doi: 10.1111/bjh.13614.
  • 10ChungNG, LeeJW, JangPS, et al. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia [J]. Pediatr Transplant, 2013, 17 (4):387–393. doi: 10.1111/petr.12073.

引证文献5

二级引证文献26

中华血液学杂志
2016年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部